Astra Tech announces implant success rate

Astra Tech, the medical devices company that is a subsidiary of AstraZeneca, has said that its dental implants have achieved a 99 per cent success rate in its patients.

A 15 country-wide international study has revealed that even in difficult cases, the company’s dental implants have a high success rate.

“In spite of the fact that 80 per cent of the implants were placed in critical areas of poor jawbone quality, we have reached a success rate of 95 per cent, using an early loading protocol in the area of the upper jaw,” said one of the dentists involved in the study, Professor Clark M Stanford of the University of Iowa.

The overall success rate across all case categories was an impressive 98.6 per cent Astra Tech has said, with many dentists praising OsseoSpeed, the fluoride-modified titanium surface that attracts and stimulates bone-building cells at the implant site.

Astra Tech has said that the success rate of its dental implants is the result of more than 15 years of research and development carried out by the company.

© Adfero Ltd